Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses
NCT03502603
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
NCT01220674
Neurotrack Test Validation Protocol
NCT02608021
Study to Validate a Computerized Neuropsychological Test Battery
NCT01421446
Development of a Neurocognitive Screening Test
NCT02597504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal patients
for patients with normal score on neurological testing with Folstein Mini-Mental Status Exam will then take the Scenes Task
Neurological testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurological testing
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must be able to provide informed consent
Exclusion Criteria
* Patients with known brain lesions
* Patients with history of stroke, neurologic disease or dementia
* Patients with acute illness or who are in imminent distress
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Englewood Hospital and Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Young, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Englewood Hospital and Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Englewood Hospital and Medical Center
Englewood, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-12-471
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.